| Literature DB >> 33333189 |
Antonio Bozzani1, Maura Pallini2, Vittorio Arici2, Guido Tavazzi3, Giulia Ticozzelli4, Mila Maria Franciscone2, Vittorio Danesino2, Francesco Mojoli2, Franco Ragni2, Antonio V Sterpetti5.
Abstract
INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection represents a serious threat to public health because it leads to a wide spectrum of clinical manifestations. The region Lombardia (Italy) has suffered from severe problems during the acute phase of the outbreak in Italy (March-April 2020). The aim of our analysis is to report the experience of the Department of Vascular Surgery of Pavia, including the learned lessons and future perspectives, considering that the COVID-19 outbreak is in its acute phase in other continents.Entities:
Year: 2021 PMID: 33333189 PMCID: PMC7832376 DOI: 10.1016/j.avsg.2020.12.001
Source DB: PubMed Journal: Ann Vasc Surg ISSN: 0890-5096 Impact factor: 1.466
Operative vascular procedures at the vascular surgery department of Fondazione IRCCS Policlinico San Matteo of Pavia
| Procedure | March 1–April 30, 2020 | March 1–April 30, 2019 | ||
|---|---|---|---|---|
| Emergency | Elective | Emergency | Elective | |
| AAA | ||||
| EVAR | 2 | 0 | 4 | 12 |
| OPEN | 0 | 0 | 5 | 18 |
| CAROTID | ||||
| CAS | 0 | 0 | 0 | 3 |
| CEA | 0 | 0 | 5 | 27 |
| PAD | ||||
| PTA/STENT | 9 | 0 | 8 | 18 |
| OPEN | 6 | 0 | 6 | 12 |
| ACUTE THROMBOSIS | 6 | 0 | 8 | 0 |
| AMPUTATION | 4 | 0 | 3 | 9 |
AAA, abdominal aortic aneurysm; EVAR, endovascular aortic repair; CAS, carotid artery stenting; CEA, carotid endarterectomy; PAD, peripheral arterial disease; PTA, percutaneous transluminal angioplasty.
Mortality in hospitalized COVID-19 patients with DVT (laboratory values refer to the time of diagnosis)
| Parameter | Mortality (9 patients) | No mortality (23 patients) | |
|---|---|---|---|
| Sex (M/F) | 8/1 | 16/7 | |
| Age (mean; range) | 71.2 (62–83) | 58.8 (30–94) | |
| Comorbidities (mean) | 4 (3–5) | 3 (2–4) | |
| Oxygen Therapy | |||
| High flow | - | 4 | |
| Noninvasive mechanical ventilation | 4 | 7 | |
| Invasive mechanical ventilation | 5 | 12 | |
| Thrombosis Localization | |||
| Lower limb proximal | 5 | 7 | |
| Lower limb distal | 2 | 10 | |
| Upper limb | 2 | 6 | |
| Evidence pulmonary embolism | 4 | 4 | |
| Padua score (mean, range) | 3.6 (3–4) | 3.2 (3–4) | |
| Platelet (mean:range) | 272 (112–669) | 242 (139–324) | |
| Fibrinogen | 418 (122–657) | 397 (172–717) | |
| PT | 57.6 (37–74) | 75.7 (36–118) | |
| aPTT | 25 (20–34) | 25 (20–43) | |
| D-dimers | 25,270 (10,800–35,000) | 14,430 (985–35,000) | |
| LDH | 482 (276–778) | 437 (250–876) | |
| Creatinine kinase | 362 (15–2,264) (100) | 124 (15–842) (78) | |
| CRP | 26.3 (1.4–100) | 16.7 (0.1–33.6) | |
| WBC | 10.4 (1.4–21.3) | 10.6 (3.7–18) | |
CRP, C-reactive protein (mg/dL) Platelet (×103/mcL); PT, prothrombin time (%); aPTT, activated thromboplastin time (%); D-dimers (mcg/L); LDH, lactate dehydrogenase (mU/mL); Creatinine kinase (mU/mL); WBC (white blood count).